Phase 1 study of the anti-HER3 antibody drug conjugate U3-1402 in metastatic or unresectable EGFR-mutant NSCLC Meeting Abstract
| Authors: | Janne, P. A.; Yu, H. A.; Johnson, M. L.; Vigliotti, M.; Shipitofsky, N.; Guevara, F. M.; Chen, S.; Yu, C. |
| Abstract Title: | Phase 1 study of the anti-HER3 antibody drug conjugate U3-1402 in metastatic or unresectable EGFR-mutant NSCLC |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 487s |
| Language: | English |
| ACCESSION: | WOS:000442916008014 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS9110 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS9110 -- Source: Wos |
